Unknown

Dataset Information

0

EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target.


ABSTRACT: Epstein-Barr virus (EBV) is a ubiquitous human tumor virus, which contributes to the development of lymphoproliferative disease, most notably in patients with impaired immunity. EBV-associated lymphoproliferation is characterized by expression of latent EBV proteins and ranges in severity from a relatively benign proliferative response to aggressive malignant lymphomas. The presence of EBV can also serve as a unique target for directed therapies for the treatment of EBV lymphoproliferative diseases, including T cell-based immune therapies. In this review, we describe the EBV-associated lymphoproliferative diseases and particularly focus on the therapies that target EBV.

SUBMITTER: Toner K 

PROVIDER: S-EPMC8854679 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target.

Toner Keri K   Bollard Catherine M CM  

Blood 20220201 7


Epstein-Barr virus (EBV) is a ubiquitous human tumor virus, which contributes to the development of lymphoproliferative disease, most notably in patients with impaired immunity. EBV-associated lymphoproliferation is characterized by expression of latent EBV proteins and ranges in severity from a relatively benign proliferative response to aggressive malignant lymphomas. The presence of EBV can also serve as a unique target for directed therapies for the treatment of EBV lymphoproliferative disea  ...[more]

Similar Datasets

| S-EPMC6428703 | biostudies-literature
| S-EPMC9063483 | biostudies-literature
| S-EPMC6400835 | biostudies-literature
| S-EPMC10652706 | biostudies-literature
| S-EPMC9562648 | biostudies-literature
| S-EPMC9500012 | biostudies-literature
| S-EPMC5573124 | biostudies-other
| S-EPMC4618620 | biostudies-literature
| S-EPMC7306156 | biostudies-literature